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ABSTRACT
Objectives: To determine 1) the sensitivity of contrast-enhanced CT (CECT) for detection of
primary canine insulinomas and metastases 2) the sensitivity of CECT to locate canine
insulinomas within the pancreas and 3) the CECT attenuation pattern of canine insulinomas
and post-contrast phase in which insulinomas have the best visibility.
Methods: A retrospective review was performed of the medical records of 27 canine insulinoma
patients. Simultaneous occurrence of blood glucose < 3.5 mmol/L (reference interval: 4.2–
5.8 mmol/L) and plasma insulin > 10 mIU/L (reference interval: 1.4–24.5 mIU/L) were
considered diagnostic for insulinoma. The dogs had a mean age of 9.0 § 1.7 (SD) years and
comprised 11 males and 17 females.
Results: Using CECT-scans, 26/27 insulinomas were successfully detected. However, CECT-scans
predicted the correct location of insulinomas within the pancreas in only 14/27 dogs. In 9/13
inaccurately located insulinoma cases, the location error was major. There was no significant
difference between triple, double and single-phase CECT-scans with location accuracies of 54%,
50% and 50%, respectively. Also, there was no specific post-contrast phase in which
insulinomas could be visualised best. Detection of lymph node metastases with CECT-scans had
a sensitivity of 67% (10/15 lymph node metastases). Detection of liver metastases had a
sensitivity of 75% (6/8 liver metastases). This study highlights that major location errors mainly
occurred if single- or double-phase CECT-scans were used (6/9 cases).
Conclusion: It is suggested that triple-phase CECT-scans have superior outcome over single- or
double-phase CECT-scans in pre-operative imaging of canine insulinomas.
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1. Introduction
Canine insulinomas are uncommon tumours of the
pancreatic beta-cells that autonomously produce insu-
lin, leading to hypoglycaemia (Madarame et al. 2009).
Although canine insulinomas are rare, they are the
most common malignant pancreatic endocrine
tumours in the dog (Tobin et al. 1999). At time of diag-
nosis, 40%–50% of the insulinomas have already meta-
stasised either to the regional lymph nodes or the liver
(Leifer et al. 1986; Trifonidou et al. 1998). Based on sur-
vival analysis, surgical resection of the primary insuli-
noma and metastases, followed by medical therapy if
required, is considered to be the better treatment
option compared to medical therapy alone (Tobin
et al. 1999; Polton et al. 2007).
Use of diagnostic imaging techniques, including
transabdominal ultrasonography, contrast-enhanced
ultrasonography, computed tomography (CT), single-
photon emission computed tomography and somato-
statin receptor scintigraphy, have been reported in the
identification and pre-operative staging of canine insu-
linomas (Lamb et al. 1995; Garden et al. 2005; Robben
et al. 2005; Nakamura et al. 2015). CT has proven to be
the most sensitive method and has become the imag-
ing modality-of-choice in pre-operative staging of
canine insulinomas. Conventional CT has reported to
have a sensitivity of 71% in detecting canine insulino-
mas. However, improved dual- or triple phase contrast-
enhanced CT (CECT) correctly identified canine insuli-
nomas in all 12 dogs from two different studies (Mai
and Caceres 2008; Fukushima et al. 2016).
Pre-operative staging of insulinomas using diagnos-
tic imaging techniques is of utmost importance. First
of all, it provides valuable prognostic information as
dogs with insulinomas with distant metastases have
shorter survival times than dogs where the insulinoma
is restricted to the pancreas and regional lymph nodes.
Diagnostic imaging can also provide detailed informa-
tion on the location of the insulinoma within the pan-
creas, which is important in surgical planning for
insulinoma resection. Tumours located in the distal
pancreatic lobes are often easily resected, while those
located in the pancreatic body and closely associated
proximal portions of the pancreatic lobes pose more of
a surgical challenge to prevent damage to the
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pancreatic ducts and the pancreaticoduodenal arteries
(Buishand and Kirpensteijn 2016). When considering
laparoscopic excision of a canine insulinoma, it is even
more important to determine the exact location of the
insulinoma as it affects the decision to perform an
open or laparoscopic surgical approach (Buishand
et al. 2015). Sternal recumbency provides good laparo-
scopic access to the right lobe and the distal part of
the left pancreatic lobe when a right or left-sided flank
approach is used, but it is challenging or even impossi-
ble to reach the proximal left lobe or the corpus. In dor-
sal recumbency, the corpus and proximal part of the
left lobe can be visualised more easily than the distal
pancreatic lobe, because moving the omentum and
stomach cranially becomes more difficult further to the
left side. Therefore, the ideal diagnostic imaging tech-
nique for insulinomas should be able to distinguish the
exact insulinoma location either in the distal, proximal
lobes or pancreatic body, in order to allow optimal pre-
operative planning.
Although CECT has proven to be very sensitive in
diagnosing canine insulinomas (Mai and Caceres 2008;
Fukushima et al. 2016), no data are available on the
sensitivity of CECT for the location of canine insulino-
mas within the pancreas. Also, the sensitivity and spec-
ificity of diagnosing both primary insulinomas and
metastases using CT-scans have only been analysed in
a small number of dogs (Robben et al. 2005). Likewise,
the largest case series describing the attenuation pat-
tern of CECT only included nine dogs and demon-
strated heterogenous enhancement patterns
(Fukushima et al. 2016). Therefore, the goals of this
study are to determine 1) the sensitivity of CECT for
detection of primary canine insulinomas and metasta-
ses 2) the sensitivity of CECT for the exact location of
canine insulinomas within the pancreas, and 3) the
CECT attenuation pattern of canine insulinomas and
post-contrast phase in which insulinomas have the
best visibility.
2. Materials and methods
2.1. Cases
A retrospective review was performed of the medical
records of canine insulinoma patients presented at the
Department of Clinical Sciences of Companion Ani-
mals, Faculty of Veterinary Medicine, Utrecht University
between 2005 and 2015. Dogs underwent single-, dou-
ble-, or triple-phase CT, and data were available for
evaluation. Insulinomas were surgically removed by an
ECVS board certified surgeon (SvN or JK) using a
LigaSureTM small jaw open instrument or LigaSureTM V,
5 mm shaft diameter (Covidien/Medtronic B.V., Heer-
len, The Netherlands), as previously described (Wouters
et al. 2011). Precise location of primary insulinoma (in
the pancreatic body, proximal or distal half of the left
or right lobe) was documented and the organ palpated
for other masses. Furthermore, the abdominal lymph
nodes and liver were also inspected and palpated for
masses. Intra-operative glucose measurements were
recorded demonstrating that normoglycaemia had
returned after insulinoma and/or metastases resection,
to assure that resection of macroscopic disease was
complete. All insulinomas and metastases were con-
firmed by histological examination.
Intra-operative locations were based on standard
anatomical landmarks. The pancreatic body was
defined as the area where the left and right pancreatic
lobes unite and where the cranial pancreaticoduodenal
artery and gastroduodenal vein enter the pancreas.
The descending duodenum was used as an anatomical
landmark for the right pancreatic lobe and the dorsal
extremity of the spleen and the gastric fundus were
used as landmarks for the left lobe. The proximal half
of a pancreatic lobe was identified as the half of the
lobe closest to the pancreatic body. Similarly, the distal
half was the part of the lobe located most distal to the
pancreatic body.
Clinico-pathological characteristics of insulinomas
included in this study are summarised in Table 1. The
simultaneous occurrence of blood glucose
< 3.5 mmol/L (reference interval (RI): 4.2–5.8 mmol/L)
and plasma insulin > 10 mIU/L (RI: 1.4–24.5 mIU/L)
were considered diagnostic for insulinoma (Fernandez
et al. 2009). Twenty-seven dogs could be included in
the study. Five dogs underwent a second CECT-scan
because of reoccurence of hypoglycaemia after partial
pancreatectomy and one dog underwent a third CECT-
scan because of relapse of clinical signs after a second
treatment, rendering a total of 33 CECT-scans (Table 2).
2.2. Computed tomography
All dogs were classified as ASA 3 based on the ASA
physical status classification system of the American
Society of Anesthesiologists (Pierce 1990). Dogs were
premedicated with 0.5 mg/kg BW IM methadone;
anaesthesia was induced with 4–6 mg/kg BW IV propo-
fol and maintained with 5–20 mg/kg BW/hour IV fenta-
nyl and isoflurane in 100% oxygen delivered through a
cuffed endotracheal tube. After induction of general
anaesthesia, dogs were positioned in dorsal (n = 31
studies) or ventral recumbency (n = 2 studies) on the
CT table using a single-slice CT scanner (Philips Secura,
Philips NV, Eindhoven, The Netherlands) (n = 26 dogs /
32 studies) or a 64-slice CT scanner (Siemens SOMA-
TOM Definition AS, Siemens Nederland, Den Haag, The
Netherlands) (n = 1 dog / 1 study). Short-term apnea
was induced with manual hyperventilation for all dogs.
Scans were made in helical acquisition mode with a
slice thickness of 2–7 mm and a pitch of 1–1.5, depend-
ing on patient size. The kVp and mA were not standar-
dised. The field-of-view was selected to include the
2 F. O. BUISHAND ET AL.
















1 Maltese FC 4.8 0.29 11 3.2 38 1.0 III
2 Jack Russell terrier FC 6.5 0.35 12 2.4 11.2 1.0 I
3 Boxer M 44.8 1.27 8 3.0 46 1.0 IV
4 Crossbred MC 23.2 0.82 10 3.0 39 1.0 I
5 Irish Softcoated
Wheaten terrier
MC 20.8 0.76 12 3.4 31 1.2 I
6 Crossbred MC 33.1 1.04 8 3.3 – 1.5 IV
7 West Highland white
terrier
FC 6.7 0.36 10 3.6 37.2 1.3 I
8 Labrador Retriever M 30.7 0.99 8 2.8 15 1.0 I
9 Braque Francais FC 21.2 0.77 8 2.7 13 2.0 II
10 Border Collie F 20.9 0.77 7 3.0 18 0.5 I
11 Field Spaniel M 26.1 0.89 9 1.8 107 1.5 IV
12 Flatcoated Retriever M 37.8 1.14 7 2.9 25 2.5 II
13 West Highland white
terrier
FC 7.6 0.39 11 1.6 64 1.5 IV
14 Boxer MC 34.5 1.07 8 2.8 16 2.0 II
15 Jack Russell terrier FC 3.2 0.22 9 2.4 111 2.0 III
16 Jack Russell terrier FC 9.2 0.44 11 2.4 29 1.5 I
17 Basset Artesien
Normand
FC 19.6 0.73 9 3.0 18 3.0 III
18 Yorkshire terrier MC 4 0.26 8 2.7 17 1.0 I
19 Kooiker dog F 10.7 0.49 8 3.1 96 1.5 III
20 Boxer FC 36.9 1.12 11 3.1 31 3.0 III
21 Jack Russell terrier M 12 0.53 8 2.3 – 1.0 IV
22 Crossbred FC 31.1 1.00 6 2.4 – 0.5 I
23 Bearded Collie F 20.5 0.76 9 3.3 – 0.5 IV
24 Dachshund FC 9.9 0.47 8 2.8 14 1.3 III
25 Crossbred MC 41.8 1.22 7 2.8 16 1.0 I
26 Scottish Shepherd dog F 29.9 0.97 8 1.9 34 4.0 IV
27 German Pointer FC 22.5 0.81 11 2.5 29.7 3.0 II
INS, insulinoma; F, female; M, male; FC, neutered female; MC, neutered male; ND, not determined.
a Staging was performed according to Buishand et al. (2010).
















1 Triple-phase Same all phases Body Body N1 N1 M0 M0
2 Triple-phase Portal L2 L1 N0 N0 M0 M0
3a Triple-phase Arterial R1 R1 N1 N1 M0 M0
3b Double-phase – – – N0 N1 M0 M0
3c Double-phase – – – N1 N1 M0 M1
4 Triple-phase Portal L2 L2 N0 N0 M0 M0
5 Triple-phase Arterial L2 L2 N1 N0 M1 M0
6 Triple-phase Arterial Body L1 N1 N1 M1 M1
7 Triple-phase Arterial L2 L1 N0 N0 M0 M0
8 Triple-phase Portal L2 L2 N0 N0 M0 M0
9 Triple-phase Portal R1 R1 N0 N0 M0 M0
10 Triple-phase Same all phases R2 R2 N0 N0 M0 M0
11 Triple-phase Same all phases L2 L1 N1 N1 M1 M1
12 Triple-phase Arterial L1 Body N0 N0 M0 M0
13 Triple-phase – No lesion L2 N0 N0 M1 M1
14 Double-phase Arterial L1 L1 N0 N0 M1 M0
15a Double-phase Arterial L1 L1 N0 N0 M0 M0
15b Double-phase – – – N0 N1 M1 M1
16 Double-phase Arterial L2 L2 N0 N0 M1 M0
17 Double-phase Arterial R1 + L1 Body N1 N1 M0 M0
18 Double-phase Portal L2 L2 N0 N0 M0 M0
19a Double-phase Same all phases Body R2 N0 N1 M0 M0
19b Single-phase – – – N0 N1 M0 M0
20 Double-phase Portal Body L2 N0 N1 M1 M0
21 Double-phase Delayed L2 L1 N1 N0 M0 M1
22 Double-phase Portal R1 L2 N0 N0 M0 M0
23a Double-phase Portal R2 R2 N1 N1 M0 M0
23b Double-phase – – – N1 N1 M1 M1
24a Single-phase Delayed Body R1 N0 N0 M0 M0
24b Double-phase – – – N1 N1 M0 M0
25 Single-phase Delayed R2 L2 N0 N0 M0 M0
26 Single-phase Portal R2 R2 N1 N1 M1 M1
27 Single-phase Arterial Body Body N0 N0 M0 M0
L1, proximal left pancreatic lobe; L2, distal left pancreatic lobe; R1, proximal right pancreatic lobe; R2, distal right pancreatic lobe; N0, no evidence of
lymph node metastasis; N1, lymph nodes involved; M0, no evidence of liver metastasis; M1, liver metastasis present.
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entire abdomen. Other technical settings were 0.7–
1 sec tube rotation time, a reconstruction index of 0.5–
1, 512 £ 512 matrix, and a medium frequency recon-
struction algorithm.
After evaluation of the pre-contrast series, Iobitridol
(Xenetix® 350, Guerbet Nederland BV, Gorinchem, The
Netherlands) was administered at a dose of 700 mg IV/
kg BW delivered via the cephalic vein using an auto-
matic angiographic injection system at a fixed injection
rate of 5 mL/s (Medrad® Mark V plus, Medrad Europe B.
V., Beek, The Netherlands). Dogs underwent either a
single-phase CT (n = 5), a double-phase CT (n = 15), or
a triple-phase CT (n = 14), resulting in a total of 22 arte-
rial phases, 27 portal phases and 25 delayed phases.
These phases were acquired approximately 15 sec,
30 sec, and 90 sec after injection of contrast media,
respectively, as described previously (Iseri et al. 2007).
2.3. Computed tomography image analysis
The CT images were retrospectively reviewed by one
board-certified radiologist (FVG) blinded to intra-opera-
tive findings. Images were reviewed in a random order
using image analysis freeware (OsiriX v.5.8.2 32-bit, Pix-
meo, Geneva, Switzerland). Display settings were
adjusted as needed for optimal evaluation of the
images. Primary insulinomas were identified as mass
lesions in the pancreas and location and size were eval-
uated. In analogy to the classification that was used
during surgery, insulinoma location was classified in
either one of the following locations, using the ana-
tomical landmarks that were used during surgery: pan-
creatic body, left or right proximal lobe, or left or right
distal lobe. The CT phase during which the insulinoma
subjectively displayed the best visibility was recorded.
Furthermore, presence or absence of lymphadenome-
galy and hepatic nodular changes were recorded.
Attenuation of masses was measured using the
maximum circular region of interest (ROI) that could be
fitted to each mass. Identical ROIs were placed in the
same location in pre-contrast and all post-contrast
images. In the post-contrast images, hyper and hypo-
attenuation were defined respectively as a positive or
negative difference of at least 20 Hounsfield units (HU)
between the mass and the surrounding normal pancre-
atic parenchyma. Iso-attenuation was defined as atten-
uation within 20 HU of the normal pancreatic
parenchyma.
3. Statistical analysis
The student’s t-test was used to compare the average
age, body weight, body surface area and tumour size
of dogs with inaccurately located insulinomas versus
accurately located insulinomas. A chi-squared (x2) test
was used to assess the difference in insulinoma loca-
tion and CECT-scan type between the inaccurately
versus accurately located insulinomas. A P-value of
0.05 was considered to indicate a significant difference.
Statistical analyses were performed using Prism 7
(GraphPad Software, La Jolla, USA).
4. Results
The included dogs had a mean age of 9.0 § 1.7 (SD)
years and comprised 11 males and 16 females. The pre-
dominant breeds were Jack Russell terrier (n = 4) and
crossbred (n = 4).
Detection of primary insulinomas with CECT-scans
had a sensitivity of 96% (26/27 insulinomas). The loca-
tion sensitivity was 52%, because CECT-scans predicted
the correct location of insulinoma within the pancreas
in 14/27 dogs (Table 2). Triple-phase, double-phase
and single-phase CECT-scans had location sensitivities
of 54% (7/13 insulinomas), 50% (5/10 insulinomas) and
50% (2/4 insulinomas), respectively. Ten insulinomas
had the best visibility on CECT-scans during the arterial
phase, nine insulinomas had best visibility during the
portal phase, three insulinomas during the delayed
phase and in four cases insulinomas had the same visi-
bility in all phases (Table 2). Student’s t-tests and x2
tests demonstrated that age, body weight, body sur-
face area, tumour size, insulinoma location and CECT
type were not significantly different between dogs
with inaccurate versus accurately located insulinomas
(Table 3). The overall attenuation of insulinomas on
CECT-scans is summarised in Table 4. Lesions were
either iso- or hypo-attenuating before contrast admin-
istration, with iso-attenuation being the most common
pattern (20/26 insulinomas). After contrast administra-
tion, iso-, hypo-, and hyper-attenuation were seen in all
phases of the CECT-scans. An example of an




cases (n = 13)
Accurately located
cases (n = 14) P-value
Mean§SD Mean§SD
Age 8.7 § 1.8 9.1 § 1.6 0.55a
Weight 21.5 § 13.4 20.7 § 12.2 0.87a
Body surface
area
0.75 § 0.33 0.73 § 0.32 0.88a
Tumour size 1.6 § 0.8 1.6 § 1.0 1.00a















L1, proximal left pancreatic lobe; L2, distal left pancreatic lobe; R1,
proximal right pancreatic lobe; R2, distal right pancreatic lobe.
a Student’s t-test
b x2-test
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insulinoma that demonstrated iso-, hypo-, and hyper-
attenuation in the different phases is presented in
Figure 1. Iso- and hyper-attenuation were most com-
mon in the arterial phase (both 8/17 insulinomas). Iso-
attenuation was the most common pattern in both the
portal phase (16/23 insulinomas) and the delayed
phase (11/20 insulinomas). Insulinomas that were not
correctly located on CECT-scans did not have a distinc-
tive attenuation pattern in comparison to insulinomas
that were correctly located.
In 4/13 inaccurately located insulinomas the loca-
tion error was minor, all insulinomas predicted in the
distal left lobe based on CECT-scans were located in
the proximal left lobe. However, the predicted location
of the remaining tumours was highly inaccurate. Two
of these tumours were predicted to be in a lobe and
found in the body, while another four tumours, pre-
dicted in the body were found in either right or left
lobe. Another two tumours predicted in the right lobe
were found in the left lobe and a CECT undetected
insulinoma was only located during surgery in the dis-
tal left pancreatic lobe.
Detection of lymph node metastases (Figure 2) with
CECT-scans had a sensitivity of 67%, since 10 out of 15
metastatic lymph nodes were identified on CECT. Of
the CECT-scans that predicted an inaccurate lymph
node status, two were triple-phase CECTs, four were
double-phase CECTs and one CECT-scan only included
the delayed phase. Detection of liver metastases
(Figure 3) with CECT-scans had a sensitivity of 75% (6/8
liver metastases). Of the CECT-scans that predicted an
inaccurate liver status, one was a triple-phase CECT
and five were double-phase CECTs.
5. Discussion
This study is the first report on detection and location
sensitivity of a case series of CECT-scans of canine insu-
linomas. Despite the high sensitivity (96%) of CECT in
detecting canine insulinoma, the location sensitivity
was only 52%. A similar location sensitivity of 55% of
CECT-scans was recently reported in a study including
31 human insulinomas (Nockel et al. 2017). Another
study, including 47 human patients with insulinomas,
divided over three groups, also reported an overall
location sensitivity of CECT of 57.4%, with a range of
35.3–81.3% depending on the scanning protocol that
was used (Long et al. 2009). One of the main reasons
for the low location sensitivity is that both canine and
human insulinomas demonstrate very heterogeneous
enhancement patterns. These patterns make the inter-
pretation of the diagnostic images hard because a
well-defined specific scoring pattern is lacking. Addi-
tionally, this study pointed out that there is no specific
post-contrast phase in which insulinomas could be
visualised best. It seemed that insulinomas have the
best visibility in the arterial phase (10/26 insulinomas;
38%) demonstrating either iso-, or hyper-attenuation.
This is in contrast to an earlier study that reported
hypo-attenuation to be the most common pattern in
the arterial phase of CECT-scans of canine insulinomas
(Fukushima et al. 2016). That study only included nine
canine insulinoma cases, of which four demonstrated
hypoattenuation, three iso-attenuation, and two
hyper-attenuation. Our results are more in line with the
fact that hyper-attenuation has been reported as the
most common enhancement pattern in the arterial
phase of CECT-scans of human insulinomas (Fidler
et al. 2003). Our 6% hypo-attenuation data is also in
line with the percentage of 13% arterial phase hypo-
attenuation in human insulinomas (Fidler et al. 2003). It
remains unclear why insulinomas show such great vari-
ability in appearance on CECT-scans and more research
focused on histological features of insulinomas, like
vascularity and dispersion of connective tissue, is
required to clarify the different CECT findings.
There was no overall difference between triple-
phase, double-phase, and single-phase CECT-scans
with location sensitivities of 54% 50%, and 50%,
respectively. However, when we focused on only major
location errors, triple-phase CECT performed better
compared to double or single-phase CECTs, with major
location error rates of 17% (2/12 triple-phase scans)
versus 50% (5/10 double-phase scans) and 50% (2/4
single-phase scans). These major location errors have
to be prevented during pre-operative planning, since
these errors have the highest impact on the procedure
of surgical insulinoma resection. For instance in cases
12 and 17, surgery was complicated because it was
only noted intra-operatively that the insulinomas were
located in the pancreatic body, while they were





contrast Arterial Portal Delayed
1 Yes Iso Iso Iso Hyper
2 No Iso Hyper Iso Hyper
3 Yes Iso Iso Hyper Iso
4 Yes Iso Iso Hyper Hyper
5 Yes Hypo Hyper Hyper Hypo
6 No Iso Iso Iso Iso
7 No Hypo Hyper Iso Iso
8 Yes Iso Iso Hyper Hyper
9 Yes Hypo Iso Iso Iso
10 Yes Iso Hypo Iso Iso
11 No Iso Iso Iso Iso
12 No Hypo Hyper Iso Hypo
13 No – – – –
14 Yes Iso Hyper Iso –
15 Yes Iso Hyper Iso –
16 Yes Hypo Hyper Hyper –
17 No Iso Iso Hypo –
18 Yes Iso – Iso Iso
19 No Iso – Iso Iso
20 No Iso – Iso Iso
21 No Iso – Iso Hypo
22 No Iso – Iso Hyper
23 Yes Iso – Iso Iso
24 No Iso – – Hyper
25 No Iso – – Iso
26 Yes Hypo – Hyper –
27 Yes Iso Hyper – –
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predicted to reside in the pancreatic lobes. On the
other hand, it is interesting to note that out of 6 insuli-
nomas that were predicted to be located in the pancre-
atic body, only 2 insulinomas were actually located in
the pancreatic body. Pancreatic body location of an
insulinoma may be a contra-indication for surgery, as
depending on the exact location, there is a high risk of
damage to the ductal system and the pancreaticoduo-
denal arteries during surgery (Buishand and Kirpen-
steijn 2016). CT may not be the ideal way of
determining pancreatic body insulinoma because a CT-
based prediction of a pancreatic body location is
wrong in 67% of the cases reported here. The fact that
insulinomas were predicted to be present in the right
pancreatic lobe, but were intra-operatively detected in
the left pancreatic lobe in cases 22 and 25 could have
been due to the fact that the descending duodenum is
not always an accurate anatomical landmark for the
right pancreatic lobe. The position of the duodenum is
strongly depending on its filling (Probst and Kneissl
2001), and in these cases the duodenum could have
been located somewhat more to the left on CT, result-
ing in an aberrant prediction of the insulinomas in the
right lobe, while they were actually located in the left
lobe.
Magnetic Resonance Imaging (MRI) has been
reported to correctly identify 29/31 (94%) pancreatic
lesions in human patients with pancreatic neuroendo-
crine tumours, and has been suggested as the pre-
ferred imaging modality for human insulinomas (Owen
et al. 2001). In veterinary medicine, MRI studies of the
canine abdomen are inconsistent. However, this
Figure 1. Transverse triple-phase contrast-enhanced computed tomography (CECT) of a 7-year-old male Flatcoated Retriever (case
12) with insulinoma in the pancreatic body (black arrow). A nodule is noted deforming the contours of the pancreas. This nodule is
very mildly hypo-attenuating compared to the adjacent pancreatic parenchyma (asterisk) on pre-contrast images (A). The pancre-
atic nodule is strongly hyper-attenuating on the arterial phase (B) and remains hyper-attenuating on the portal phase (C). The
delayed phase demonstrates iso-attenuation of the pancreatic nodule (D).
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imaging technique is gaining popularity. Manley et al.
(2013) evaluated different MRI protocols for their diag-
nostic quality regarding the canine abdomen using a
1.0 Tesla magnet. More recently the perfusion and dif-
fusion characteristics of the liver in healthy dogs were
evaluated using a 3.0 Tesla magnet (Del Chicca et al.
2016). On top of that, MRI has already proven to be
superior to CT in diagnosing a canine mesenteric lym-
phoma and a large splenic tumour in a dog (Yasuda
et al. 2004; Kim et al. 2016). Further research into the
use of MRI for canine abdominal imaging is warranted.
It is expected that MRI may prove to be better in differ-
entiating between insulinoma locations (distal, mid,
proximal lobes, and pancreatic body) compared to
CECT-scans, which would facilitate pre-operative plan-
ning. There is a clear need for better pre-operative
imaging modalities, since this would facilitate the use
of laparoscopic pancreatectomy instead of traditional
open surgery. In human medicine, the minimal invasive
approach has been associated with similar or short-
ened surgery times, less blood loss, fewer complica-
tions, and decreased hospitalisation time compared to
the open approach (Tang et al. 2007; Merchant et al.
2009). Currently, except for laparoscopic or laparo-
scopic-assisted pancreatic biopsies, the use of laparo-
scopic surgery of the pancreas in companion animal
patients is not a standard procedure, and has only
been reported in one dog with an insulinoma in the
mid-left lobe of the pancreas (McClaran et al. 2017).
Although MRI seems promising, drawbacks for the use
of MRI for canine abdominal imaging could be the lim-
ited availability and prolonged image acquisition time
compared to CT.
CECT-scans demonstrated sensitivities of 67% and
75% regarding detection of lymph node and liver
metastases, respectively. There are no other case series
including at least 27 patients, comparing the sensitivity
of CECT-scans for the detection of either canine or
human insulinoma metastases. However, these sensi-
tivities are in line with those reported for other human
abdominal epithelial tumours (Lee et al. 2009; Wang
et al. 2013; Servaes et al. 2015; Schulz et al. 2016). Our
case series included two cases that demonstrated
abnormal lymph nodes on CECT-scans, but no lympha-
denomegaly was found during surgery. Although it is
unlikely that these were metastatic lymph nodes, we
Figure 2. Transverse triple-phase contrast-enhanced computed tomography (CECT) in an 8-year-old neutered male crossbred (case
6) with metastatic insulinoma lymphadenopathy. The pancreaticoduodenal lymph node (black arrow) is enlarged and round. The
lymph node is homogenously iso-attenuating on pre-contrast images (A) and all post-contrast phases (arterial (B), portal (C) and
delayed venous (D)), demonstrate hyper-attenuation.
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cannot exclude that these lymph nodes contained
micrometastases, because only lymph nodes that were
abnormal on palpation were sampled.
The present study has several limitations. First of all,
this study was retrospective in nature and was con-
ducted at an academic referral clinic, which might
have resulted in a biased patient population, since the
referring veterinarian may have treated the insulino-
mas that were easy to localise. Furthermore, although
body weight and body surface area were not signifi-
cantly associated with CECT location sensitivity, using
the same contrast medium injection protocol for all
dogs may have affected the results of the enhance-
ment patterns. It takes more time for injection of the
contrast medium in large breed versus small breed
dogs. Therefore, to reduce the heterogeneity in
enhancement patterns it might be advisable to use
more precise methods, like a test injection or bolus-
tracking method for canine pancreatic CECT imaging.
Only one board certified veterinary radiologist scored
the CECT images. The sensitivity, specificity and
location sensitivity of the CECT-scans may be improved
if multiple radiologists would score the CECT images.
Although the radiologist was blinded to the intra-oper-
ative location of the insulinomas, he did know that all
cases had insulinoma. This bias could explain why
there were major location errors in some cases. In all
cases a potential pancreatic insulinoma location was
identified, even when the mass was not clearly visible
in any of the contrast series. Other factors that could
have contributed to a low overall location sensitivity is
the use of a single-slice CT scanner for the majority of
the patients and the use of varying slice thickness. The
overall sensitivity, specificity and location sensitivity
might improve if a 64-slice CT scanner with a standar-
dised triple-phase CT protocol is used. Also, the use of
poor anatomical landmarks could have played a role in
the inaccurate location prediction of insulinomas with
CT imaging, because of differences between patients
in terms of location, size and position of the pancreas
and the organs that were used as anatomical
landmarks.
Figure 3. Transverse triple-phase contrast-enhanced computed tomography (CECT) in an 8-year-old neutered male crossbred (case
6) with a hepatic insulinoma metastasis. A well-defined nodule is noted in the periphery of the left lateral hepatic lobe (black arrow
head). The nodule is hypo-attenuating on pre-contrast images (A). During the arterial phase the nodule shows homogeneous
strong enhancement (B). The center of the nodule remains hyper-attenuating during the portal and delayed venous phases with a
less attenuating periphery (C and D).
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In conclusion, there was no difference in location
sensitivities between triple-phase, double-phase and
single-phase CECT-scans. However, major location
errors mainly occurred if single- or double-phase con-
trast-enhanced CECT-scans were used (6/9 cases).
Therefore, we suggest that triple-phase CECT-scans
have superior outcome over single- or double-phase
CECT-scans and future prospective studies in a mixed
population of dogs with and without insulinomas are
required to support this theory.
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